113 related articles for article (PubMed ID: 15743898)
1. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model.
Yu J; Wu J; Francis KP; Purchio TF; Kadurugamuwa JL
J Antimicrob Chemother; 2005 Apr; 55(4):528-34. PubMed ID: 15743898
[TBL] [Abstract][Full Text] [Related]
2. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
3. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
Liu Y; Cui J; Wang R; Wang X; Drlica K; Zhao X
J Antimicrob Chemother; 2005 Dec; 56(6):1172-5. PubMed ID: 16207765
[TBL] [Abstract][Full Text] [Related]
4. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
[TBL] [Abstract][Full Text] [Related]
5. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
6. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
Daurel C; Prunier AL; Chau F; Garry L; Leclercq R; Fantin B
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):344-9. PubMed ID: 17714489
[TBL] [Abstract][Full Text] [Related]
7. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
[TBL] [Abstract][Full Text] [Related]
8. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A
J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647
[TBL] [Abstract][Full Text] [Related]
9. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
Hammer KA; Carson CF; Riley TV
Int J Antimicrob Agents; 2008 Aug; 32(2):170-3. PubMed ID: 18571379
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo.
Kadurugamuwa JL; Sin LV; Yu J; Francis KP; Purchio TF; Contag PR
Antimicrob Agents Chemother; 2004 Jun; 48(6):2283-7. PubMed ID: 15155235
[TBL] [Abstract][Full Text] [Related]
11. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
[TBL] [Abstract][Full Text] [Related]
12. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters.
Aslam S; Darouiche RO
J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
14. Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin.
Rahman M; Kim S; Kim SM; Seol SY; Kim J
Biofouling; 2011 Nov; 27(10):1087-93. PubMed ID: 22050201
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
Lee JY; Ko KS; Peck KR; Oh WS; Song JH
J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB combination.
Darouiche RO; Mansouri MD; Gawande PV; Madhyastha S
J Antimicrob Chemother; 2009 Jul; 64(1):88-93. PubMed ID: 19447791
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
19. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
20. The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden.
Hurdle JG; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2004 Jan; 53(1):102-4. PubMed ID: 14657089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
